Walder Wyss has advised co-led investors Swisscanto and imec.xpand. Nagi Bioscience’s has closed its Series A Financing round in the amount of CHF 12.4m, Seisscanto and...
Nagi Bioscience’s CHF12.4 Million Fundraise
90 Institutional Investors v. Vivendi
Soffer Avocats advised investors on the deal, while Freshfields and Darrois Villey Maillot Brochier represented Vivendi. The French court overseeing a decade-long shareholder securities fraud lawsuit...